y p e r e k p l e x i a , or startle years of life. The severity of the disorder disease, is an autosomal in adults is determined by the frequency dominant disorder charof startle responses; it varies consideracterizedby exaggerated ably, not only between subjects but also startle reactions to unex pected, particularly auditory, stimuli. over time.
From the Department of
Besides patients with the major form, Suhren et al1 described the syndrome in patients with a putative "minor" form were detail in a large Dutch family in 1966. Subdescribed based on excessive startle reacsequent reports2'8 have confirmed its fations without stiffness. In the Dutch fammilial occurrence. In the Dutch family, two ily, patients with the major form had Figure 1) . A history was obtained from 76 age analysis was performed on individual, sibships and on individuals (32 patients and 44 unaffected relatives), and the complete pedigree; evidence for or against linkage is given a neurologic examination was performed in 61 individuas logarithm base 10 of the odds in favor of linkage (lod score), als (31 patients and 30 unaffected relatives) from four Initially, only the classic form of hyperekplexia was scored generations. In 15 subjects, no neurologic examination in ; linkage am minor form or PLMS was performed: one patient (patient IV-3) refused, while were treated as unaffected. The hypothesis of the excessive 14 unaffected family members lived far from our hospistartle reaction being a minor form of hyperekplexia was intal. Blood samples were obtained from 59 of the 61 indi viduals examined (two patients were young children) and 15 spouses. zone The major form of hyperekplexia was defined by a hison chromosome S being responsible for PLMS in this famtory of exaggerated startle responses to auditive, tactile, or ily was investigated separately; for this purpose, the occurvisual stimuli and the presence of stiffness following the renee of excessive startle responses or stiffness was nestartle reaction. In the absence of stiffness, the minor form was diagnosed. In addition, the presence or absence of PLMS was verified, as either noted by the patients themselves or their partners. Patients were also included in this category SCANNING EXONS FOR POINT MUTATIONS glected. The frequency of PLMS in the general population was assumed to be approximately 5%,~4
when they experienced sudden body jerks on falling asleep at least once a week.
BY DGGE AND SEQUENCING OF GLRA1
GENETIC MARKER ANALYSIS Polymerase chain reaction primers within intron se quences of the GLRA1 were designed to amplify all exons from genomic DN A of affected individuals and controls (R.S., Genomic DNA was isolated from freshly collected blood, oral communication, 1994, data not shown). The goal was as previously described.17 Analysis of microsatellite to amplify the exons from DNA from individuals with hymarkers was performed with m u ltip le x polymerase chain reactions on all individual DNA samples.l7,ls The m icrosatellite m arkers in te r le u k in -9 ,19 D 5 S 2 I0 , D5S207,20 CSF1-R,21 D5S209,1 H D5S119,20 D5S422,22 and D5S21120 were included ( Figure 2 ). Reaction products were separated on a 6% denaturating polyacrylamide gel containing 7-mol/L ureum, The gels were fixed, dried, and subjected to autoradiography for 12 to 18 hours, without an intensifying screen. Marker genotypes were subsequently determined for each individual by visual inspection.
perekplexia and to use DGGE to scan for DNA sequence alterations unique to the affected individuals,16 Exons show ing an aberrant DGGE pattern were cloned and se quenced.
Polymerase chain reaction products from exon 6 were directly cloned into the pCRII vector with use of a cloning kit (Invitrogen TA, San Diego, Calif).10 Six i were sequenced on an automated sequencing apparatus (Pharmacia ALF, Uppsala, Sweden). Mutations were de tected by comparing cloned sequences with the published cDNA sequence."' Accordingly, the two forms were considered to repre sent variations in expression of the same disease gene. In other families segregating for hyperekplexia, the oc casional occurrence of the minor form has been con firmed.2,8'10 Autosomal dominant inheritance with nearly com plete penetrance and variable expressivity is seen in most pedigrees.2'5Al1,1 2 On the basis of findings obtained in small sibships, some authors suggested an autosomal reces sive inheritance pattern or the occurrence of new mutations.2' 4,6'8 '13 Hypnagogic myoclonus and periodic leg move ments during sleep (PLMS) are frequently associated with hyperekplexia. 2'i1'H ' l0,1U i'1 ' 5 The occurrence of PLMS in un affected sibs has not been signaled.
Recently, Ryan et al7,12 mapped a hyperekplexia lo cus on chromosome 5q33-q35 in four families with the major form of hyperekplexia. Further studies identified point mutations in the gene encoding the a l subunit of the glycine receptor (GLRA1). Two different mutations were found in the same position, resulting in substitu tion of an uncharged amino acid (leucine or glutamine) for Arg271 in the mature protein. 16 Neither the minor form of hyperekplexia nor the occurrence of PLMS was discussed in those studies.
The first aim of our study was to confirm linkage of the major form of hyperekplexia on chromosome 5q33 in the Dutch hyperekplexia pedigree. Second, we tested whether the family members with the putative minor form had inherited the chromosome with the major hyperek plexia gene defect, as determined by haplotyping. The third aim was to record the occurrence of PLMS in the pedi gree in relation to the genetic markers. Finally, we scanned the gene for GLRA1 for point mutations using denatur ing gradient gel electrophoresis (DGGE) in patients with the major and minor form, and sequenced exon 6.
R E S U L T S stimuli were found in 44 patients (22 male and 22 fe male), 32 of whom were alive at the time of investigation. Stiffness in addition to the startle reaction occurred in 28 of the 44 patients, indicating, according to the definition, the major form; 23 of these were known to have had gen eralized stiffness directly after birth. No reliable informa- (Figure 1 ). All patients who were known to have had stiffness at birth also suffered from stiffness in re lation to the startle reaction. Among 44 patients with ex cessive startle reactions, 16 had never manifested stiffness either after startle or at birth; these patients had the minor form of hyperekplexia.
The transmission of the major form of hyperekplexia in this family was consistent with autosomal dominant in heritance. The major form was frequently passed on as the major form and four times as the minor form. However, those with the minor form only passed on the minor form, never the major form. Patient III-8 seemed to be one ex ception to this rule (Figure 1 ). In 1966, he had reported an excessive startle reaction without stiffness and passed the major form of the disease on to his children. However, based on detailed family history of several close relatives, who reported to have seen him fall several times owing to generalized stiffness in relation to his startle reaction, he is now considered to have the major form.
In T a b le I , evidence for linkage between each of the chromosome 5 markers and the major form of hy perekplexia is presented as lod scores. Close linkage with out recombination was found between markers CSF1-R, D5S209, and D5S119 and the disease locus. For these markers, an identical haplotype was found in all 19 pa tients with the major form, indicating tight linkage. Of the 10 patients with the putative minor form, three (patients 111-5, IV-11, and V-66) had a haplotype simi lar to those patients with the major form, but seven had different haplotypes. This is consistent with what one would expect based on chance alone. Individuals with PLMS are also shown in Figure 1 . The frequency of PLMS in patients with the major form or the minor form of hyperekplexia and the healthy sibs is pre sented in T a b le PLMS occurs with high frequency in all three groups. Exclusion of tight linkage between the DNA markers and PLMS is evidenced by the highly negative lod scores obtained at small values of the recombination fre quency (Table 3) . Interestingly, marker D5S209 yielded positive lod scores at higher recombination frequencies, con sistent with a location of PLMS more than 20 cM away from this marker. However, this tentative location was not con firmed by markers located at some distance of D5S209, such as D5S210 and D5S422.
By screening the exons of GLAR1 with DGGE, a change was found in exon 6 in a patient with the major form of hyperekplexia (patient IV-14). After cloning exon 6 of this patient, sequencing eight clones showed that three had the wild type sequence, while five had a G to A mu tation in codon 271, reflecting the heterozygotic state of the patient. A patient (patient IV-11) with the minor form of hyperekplexia showed no change by screening with DGGE, and no further sequencing was performed. No changes were found with DGGE in a patient with PLMS (patient IV-19).
COMMENT
Clinical studies in families with hyperekplexia have re ported highly variable expression, including major and minor forms.1 '8'11,13 This variability might in fact reflect 
markers CSF1-R, D5S119, D5S209, and D5S379 in four families with an autosomal dominant additional studies based on the linkage results, point mu tations were found in GLAR1. In the families studied, stiff ness at birth and/or in relation to the startle reaction were invariably present and considered the criterion for the disease (major form).
In our family, comprising both the major and the putative minor form of hyperekplexia, we confirmed link-CSF1 -R, mar same 'sis was con and the major form hyperekplexia locus. The same marker alleles that were shared by all patients with the major form were found only in a minority (three of 10) of the pa tients with the minor form, suggesting that the minor form is not part firmed by screening GLRA1 with DGGE. Patients with the major form showed a mutation in exon 6. By se quencing exon 6, a G to A transition in codon 271 was found. Patients with the minor form did not have this mutation. Together, these results exclude the possibil ity that major and minor forms of hyperekplexia consti tute different phenotypes of the same, gene defect. Therefore, the question arises whether the minor form does in fact constitute an integral part of the dis ease. A common genetic basis for the major and minor forms appeared to be plausible in the original evalua tion of this pedigree, as the major form was once trans mitted trough a patient with the minor form. However, it has subsequently become clear that this patient, who had not volunteered any information on stillness follow ing startle response, should be classified as having the major form of the disease based on independent family history information from several close relatives.
In other reports, the number of patients with stiffto reaction varies. In most large families, all patients hi form.i,,5'u,14,1P',2' s However, in four families and the minor forms occurred. In these jor was passed on as the minor m ma-'>, [8] [9] [10] [11] It is important to realize that only one or two patients had the major form of hyperekplexia in these families. occurrence ekplexia are caused by a single gene defect, one might sug gest alternatively that apart from the major hyperekplexia gene, on the chromosome 5q, another gene elsewhere in the genome is responsible for the minor form of hyperekplexia. The rarity of the disease makes the presence of two muta tions in one pedigree veiy unlikely. However, it remains pos sible that the occurrence of an excessive startle response as an autosomal dominant or sporadic trait may be much more common than previously believed.13 Obviously, startle responses are well known by all subjects in these pedigrees, increasing the chance that pronounced but normal startle reactions are considered abnormal in a hyperekplexia pedi gree. If so, linkage studies in hyperekplexia will be com plicated by the admixture of such "other" startle, responses. For a better discrimination between normal and abnormal startle reactions, the. normal variation in motor startle re actions should be delineated further through quantitative neurophysiologic investigations. The occurrence of hypnagogic myoclonus and PLMS in the families with hyperekplexia presents another clas sification problem. Presumably, PLMS exists in 5% to 6% of the healthy population. 24 We found an occurrence of PLMS of at least 21% in nonhyperekplectic sibs of pa tients with hyperekplexia. The distribution of PLMS over the pedigree suggests an autosomal dominant inheritance of PLMS, with incomplete penetrance, unrelated to hyper ekplexia. We hypothesized that a gene for PLMS might be located in the vicinity of the hyperekplexia locus and that recombination could account for the occurrence of PLMS without excessive startle reactions. This was not con firmed by a linkage study with three markers of the hyper ekplexia locus or with the markers tested further away on chromosome 5q.
In conclusion, the present molecular genetic reevaluation of the Dutch family with hyperekplexia clearly demonstrates that only the major form constitutes part of the hyperekplexia phenotype. Stiffness, after the startle reaction and in the first years of life, is therefore the stron gest diagnostic criterion, even though the startle re sponses attract more attention.
